1. Home
  2. Live Updates
  3. Pulmonary research

Live Breaking News & Updates on Pulmonary research

Stay informed with the latest breaking news from Pulmonary research on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Pulmonary research and stay connected to the pulse of your community

Seiko Okada, M.D., Ph.D.

Seiko Okada, M.D., Ph.D.
natlawreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from natlawreview.com Daily Mail and Mail on Sunday newspapers.

United-states , Jamesa-wynn , Seiko-okada , United-states-court , Treatment-center , Seiko , Womble-bond-dickinson , Judge-james , North-carolina-cystic , Pulmonary-research ,

Philips Break-through MR 7700 System Adds Xenon Capabilities to Enhance Ventilation Imaging at ISMRM 2023

Philips’ Xenon enabled MRI combined with XENOVIEW from Polarean can provide pulmonologists, surgeons and respiratory specialists with regional maps of ventilation in patients’ lungs to assist in better managing disease states 

Toronto , Ontario , Canada , Cincinnati , Ohio , United-states , University-of-cincinnati , America , Richard-hullihen , Ruud-zwerink , Philips , Cincinnati-children-hospital-medical-center

New Research Air Pollution Particles Activate Cellular Defense Mechanisms

The link between air pollution and lung disease has long been recognized. Now a new USC study reveals one biological process that may be behind that link — a discovery which could provide new insights on better ways to treat or prevent diseases relat

Arnold-sipos , Edward-crandall , Keck-school-of-medicine , Hastings-center , Pulmonary-research , Rogers-institute-pulmonary-research-center , Will-rogers-institute-pulmonary-research-center , Keck-school ,

Study shows that airborne nanoparticles trigger autophagy in lung cells

New research from the Keck School of Medicine of USC shows that air pollution particles activate a cellular defense mechanism known as autophagy, which may reduce the ability of cells to fight off other harms. The findings were published in the journal Autophagy Reports. We know that diseases, especially lung...

Edward-crandall , Hastings-center , Rogers-institute-pulmonary-research-center , National-institutes-of-health , Keck-school-of-medicine , Whittier-foundation , Hastings-foundation , Rogers-motion-picture-pioneers-foundation , Pulmonary-research , Keck-school , Will-rogers-institute-pulmonary-research-center , Will-rogers-motion-picture-pioneers-foundation

Dupixent® (dupilumab) Late-breaking Phase 3 COPD Results Presented at ATS and Simultaneously Published in the New England Journal of Medicine

Dupixent is the first and only investigational biologic for COPD that has demonstrated a significant reduction in moderate or severe acute exacerbations by 30% compared to placebo Dupixent is the... | May 21, 2023

Japan , United-states , Paris , France-general- , France , American , Nathalie-pham , Eva-schaefer-jansen , Tarik-elgoutni , Sally-bain , Surya-bhatt , Sharon-chen

Press Release: Dupixent® (dupilumab) late-breaking Phase 3 COPD results presented at ATS and simultaneously published in the New England Journal of Medicine

Dupixent® late-breaking Phase 3 COPD results presented at ATS and simultaneously published in the New England Journal of Medicine Dupixent is the first and only investigational biologic for... | May 21, 2023

Japan , Paris , France-general- , France , United-states , American , Surya-bhatt , Sally-bain , Felix-lauscher , Sharon-chen , Tarik-elgoutni , Vesna-tosic

Dupixent® (dupilumab) Late-breaking Phase 3 COPD Results

Dupixent is the first and only investigational biologic for COPD that has demonstrated a significant reduction in moderate or severe acute exacerbations by...

United-states , Japan , Paris , France-general- , France , American , Georged-yancopoulos , Regeneron-velocimmune , Surya-bhatt , Clinical-research-program , Regeneron-genetics-center , Trial-program

Press Release: Dupixent® (dupilumab) late-breaking Phase 3

Dupixent® (dupilumab) late-breaking Phase 3 COPD results presented at ATS and simultaneously published in the New England Journal of Medicine Dupixent...

Paris , France-general- , France , Japan , United-states , American , Nathalie-pham , Sally-bain , Eva-schaefer-jansen , Sandrine-guendoul , Felix-lauscher , Sharon-chen

Sanofi - Aventis Groupe: Press Release: Dupixent® (dupilumab) late-breaking Phase 3 COPD results presented at ATS and simultaneously published in the New England Journal of Medicine

Dupixent® (dupilumab) late-breaking Phase 3 COPD results presented at ATS and simultaneously published in the New England Journal of Medicine Dupixent is the first and only investigational biologic

Japan , Paris , France-general- , France , United-states , American , Eva-schaefer-jansen , Sandrine-guendoul , Surya-bhatt , Gewinn-nur , Tarik-elgoutni , Sally-bain

Stock Market | FinancialContent Business Page

FinancialContent fully hosted finance channel

Paris , France-general- , France , United-states , Japan , American , Arnaud-delepine , Eva-schaefer-jansen , Regeneron-velocimmune , Sharon-chen , Vesna-tosic , Georged-yancopoulos